Center for Behavioral Cardiovascular Health, Department of Medicine, Columbia University Medical Center, New York, NY 10032, United States.
Center for Behavioral Cardiovascular Health, Department of Medicine, Columbia University Medical Center, New York, NY 10032, United States.
J Psychosom Res. 2014 Oct;77(4):283-6. doi: 10.1016/j.jpsychores.2014.07.009. Epub 2014 Jul 15.
Anxiety sensitivity-fear of the negative social, physical, or cognitive consequences of anxiety related sensations-has been linked to cardiovascular disease and adverse cardiovascular health behaviors. Medication nonadherence may account for this association. We examined whether anxiety sensitivity was independently associated with objectively measured medication nonadherence in a multi-ethnic primary care sample.
Eighty-eight patients with uncontrolled hypertension completed the Anxiety Sensitivity Index and had their adherence to blood pressure (BP) medications measured during the interval between two primary care visits using an electronic pillbox (MedSignals®). Multivariable Poisson regressions were conducted to determine the relative risks of medication nonadherence associated with anxiety sensitivity after adjustment for age, gender, Hispanic/Latino ethnicity, education, total number of prescribed medications, and depressive and posttraumatic stress disorder (PTSD) symptoms.
Nearly twice as many patients with high anxiety sensitivity were nonadherent to BP medications compared to patients with low anxiety sensitivity (65.0% vs. 36.8%; p=0.03). Patients with high anxiety sensitivity had higher relative risks of medication nonadherence than their low anxiety sensitivity counterparts (adjusted relative risk [RR]=1.76; 95% CI: 1.03-3.03).
In this first study of the association between anxiety sensitivity and medication adherence, we found that high anxiety sensitivity was strongly associated with BP medication nonadherence, even after adjustment for known confounders. Our results suggest that teaching patients who have uncontrolled hypertension adaptive strategies to manage their anxiety sensitivity may help improve their medication adherence, and thereby lower their cardiovascular risk.
焦虑敏感性是指对与焦虑相关感觉的负面社交、身体或认知后果的恐惧,它与心血管疾病和不良心血管健康行为有关。药物依从性差可能是造成这种关联的原因。我们在一个多民族的初级保健样本中研究了焦虑敏感性是否与客观测量的药物不依从独立相关。
88 名血压控制不佳的患者完成了焦虑敏感性指数的评估,并在两次初级保健就诊之间使用电子药盒(MedSignals®)来测量他们对血压(BP)药物的依从性。多变量泊松回归用于确定在调整年龄、性别、西班牙裔/拉丁裔、教育程度、处方药物总数、抑郁和创伤后应激障碍(PTSD)症状后,与焦虑敏感性相关的药物不依从的相对风险。
与低焦虑敏感性的患者相比,高焦虑敏感性的患者中药物不依从的患者比例几乎高出一倍(65.0% vs. 36.8%;p=0.03)。与低焦虑敏感性的患者相比,高焦虑敏感性的患者药物不依从的相对风险更高(调整后的相对风险[RR]=1.76;95%置信区间:1.03-3.03)。
在这项关于焦虑敏感性与药物依从性的关联的首次研究中,我们发现,即使在调整了已知的混杂因素后,高焦虑敏感性与 BP 药物不依从性密切相关。我们的结果表明,教导患有未控制高血压的患者采用适应性策略来管理其焦虑敏感性,可能有助于提高他们的药物依从性,从而降低他们的心血管风险。